1. Duthey, B. (2013) Background paper. Alzheimer’s disease and other dementias, in A Public Health Approach to Innovation, Update on 2004 Background Paper, pp. 1–74.
2. Lee, V., Goedert, M., and Trojanowski, J. (2001) Neurode-generative tauopathies, Annu. Rev. Neurosci., 24, 1121–1159.
3. Jayadev, S., Nochlin, D., Poorkaj, P., Steinbart, E., Mastrianni, J., Montine, T., Ghetti, B., Schellenberg, G., Bird, T., and Leverenz, J. (2011) Familial prion disease with Alzheimer’s disease-like tau pathology and clinical pheno-type, Ann. Neurol., 69, 712–720.
4. Hardy, J., and Selkoe, D. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics, Science, 297, 353–356.
5. Ryazantseva, M. A., Mozhaeva, G. N., and Kaznacheeva, E. V. (2014) The pathogenesis of Alzheimer’s disease and potassium homeostasis, in Neurodegenerative Diseases: from Genome to the Whole Organism (Ugrumov, M. V., ed.) Vol. 2, Nauka, Moscow, pp. 163–181.